- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- Out-licensing
- View
Eurand Minitabs Nifedipine SR capsules 30 and 60mg (once daily)
Full description
This client is a market leading, fully integrated drug delivery/specialty pharmaceutical company. It has development in-house improved forms of well-established compounds. The company is looking to further strengthen its franchise with major pharmaceutical companies by offerin Eurand Minitabs® Nifedipine SR capsules 30 and 60mg (once daily).
Marketing authorizations available for transfer in Brazil, Germany and Ireland.
Development status
Type of business relationship sought
The company licenses the right to customers to register and market the specialty in the territory. The company provides potential licenses with all the support needed in the pre- and post launch phases of the product i.e regulatory, manufacturing, technical, commercial…
Licensing contact
Company details
Worldwide Leader in Drug Delivery/Specialty Pharmaceuticals
Related reports
Related items
Related categories
- Industry sector
- Drug delivery
- Pharmaceutical
- Pharmaceutical / Prescription
- Therapeutic target
- Cardiovascular
- Cardiovascular / Treatments
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us